⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MGTX News
MeiraGTx Holdings plc Ordinary Shares
MeiraGTx Announces Four Posters at the European Society of Gene and Cell Therapy (ESGCT) 2026 Annual Congress and the Network of Excellence for ALS (NEALS) Annual Meeting
globenewswire.com
MGTX
Form 8-K
sec.gov
MGTX
MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
globenewswire.com
MGTX
Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical
prnewswire.com
MGTX
Form 8-K
sec.gov
MGTX
MeiraGTx Reports Second Quarter 2026 Financial and Operational Results
globenewswire.com
MGTX
Graviton BioScience Announces Clearance of Investigational New Drug (IND) for GV101 for the Treatment of Friedreich's Ataxia
prnewswire.com
MGTX
MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MGTX
MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MGTX
Form 8-K
sec.gov
MGTX